# Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

> **NCT04351373** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 12 (actual)

## Conditions studied

- Vestibular Schwannoma

## Interventions

- **DRUG:** Fluorescein Sodium
- **DEVICE:** YELLOW560 filter

## Key facts

- **NCT ID:** NCT04351373
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-06
- **Primary completion:** 2022-05-25
- **Final completion:** 2022-05-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04351373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04351373, "Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT04351373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*